Cholangiocarcinoma in a Bitch - Multimodal Diagnosis

Authors

DOI:

https://doi.org/10.22456/1679-9216.124365

Abstract

Background: Hepatic tumors of primary origin account for 0.6% to 2.9% of cases in canine species, less common than hepatic metastases. The hepatic tumors are divided into hepatocellular tumors, neuroendocrine tumors, bile duct tumors or cholangiocarcinomas, and mesenchymal tumors. Cholangiocarcinomas, are classified according to their origin, being intrahepatic, extrahepatic, or gallbladder type. Cholangiocarcinomas are considered rare in dogs and cats with a ratio of 29% to 71% compared to hepatocellular carcinomas, accounting for 9% of the hepatic tumors. The present study aims to describe a case of cholangiocarcinoma in a bitch, focusing on the diagnostic approach.

Case: A 10-year-old castrated bitch Poodle was attended presenting hypoglycemia and seizure crisis. The patient had previous exams of hemogram and serum biochemical profile, showing a discrete increase of the hepatic enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST), besides hypoglycemia. Previous ultrasound exam revealed the presence of a hepatic mass located between the right and square lobes, immeasurable, and significant splenomegaly. Abdominal palpation revealed the presence of immeasurable abdominal formation of undetermined origin. Abdominal computerized tomography (CT), glycemic curve, and insulin dosage were requested. Tomography exam showed an increase in hepatic volume with the presence of a heterogeneous formation in the right lateral lobe topography; increase in spleen dimensions and the presence of multiple nodules; and the presence of a nodule in the right lung, at the caudal thoracic region. The glycemic curve showed acute variations, and insulin dosage was between normal values. The animal was referred for surgery, as in abdominocentesis, it was observed the presence of hemorrhagic fluid, confirming active bleeding by ultrasonography. The owners chose for euthanasia. In the post-mortem evaluation the main lesion was confirmed of hepatic origin, with a massive, irregular, cavitary presentation, involving multiple hepatic lobes, and a single nodule was observed in the right caudal lobe of the right lung. Histopathological evaluation was considered inconclusive. Immunohistochemistry was performed and the association of the immunohistochemical profile with the morphological characteristics indicated diagnosis of cholangiocarcinoma.

Discussion: The related symptomatology, in hepatic neoplasms, is generally considered non-specific, with reports of lethargy, vomiting, dyspnea, anorexia and weight loss, however, the dog in this study presented a unique manifestation of hypoglycemia and one episode of convulsive crisis resulting from it. The clinical manifestation observed was extremely unspecific making initial diagnosis difficult. The ultrasonographic examination was effective in evidencing the abdominal mass. In addition, abdominal CT was also performed, which confirmed the hepatic origin, detailing the macroscopic aspect. Biochemical analyses of ALT and AST showed a discrete increase. Biochemical changes may occur in dogs with hepatic neoplasms, although they are not specific. Functional pancreatic beta-cell tumors producing insulin are the most common cause of paraneoplastic hypoglycemia, although in the case the insulin dosage was within normal limits. In cases of non-islet cell tumor the mechanism is frequently associated with the production of insulin-like growth factor (IGF). In most cases the definitive diagnosis of cholangiocarcinoma can be obtained by histopathological examination, although in the present report the result obtained was inconclusive, requiring an immunohistochemical examination. Due to the aggressive and metastatic character of this neoplastic type, early detection becomes extremely important in order to maximize therapeutic chances, however, diagnosis may be difficult.

Keywords: hepatic neoplasm, dog, biliary carcinoma, immunohistochemistry.

Downloads

Download data is not yet available.

References

Bargellini P., Orlandi R., Paloni C., Rubini G., Fonti P., Righi C., Peterson M.E., Rishniw M. & Boiti C. 2018. Contrast‐enhanced ultrasound complements two‐dimensional ultrasonography in diagnosing gallbladder diseases in dogs. Veterinary Radiology & Ultrasound. 59(3): 345-356. DOI: 10.1111/vru.12601 DOI: https://doi.org/10.1111/vru.12601

Daleck C.R. & Nardi A.B. 2016. Oncologia em Cães e Gatos. 2.ed. Rio de Janeiro: Roca, pp.615-624.

Dynkevich Y., Rother K.I., Whitford I., Qureshi S., Galiveeti S.L., Szulc A.L., Ann Danoff A., Breen T.L., Kaviani N., Shanik M.H., LeRoith D., Vigneri R., Koch C.A. & Roth J. 2013. Tumors, IGF-2 and Hypoglycemia: Insights from the clinic, the laboratory and the historical archive. Endocrine Reviews. 4(6): 798-826. DOI: 10.1210/er.2012-1033 DOI: https://doi.org/10.1210/er.2012-1033

Flores M.M., Bianchi R.M., Kommers G.D., Irigoyen L.F., Barros C.S.L. & Fighera RA. 2013. Prevalência e achados epidemiológicos, anatomopatológicos e imuno-histoquímicos dos tumores hepáticos malignos primários de cães da Região Central do Rio Grande do Sul (1965-2012). Pesquisa Veterinária Brasileira. 33(4): 497-511. DOI: 10.1590/S0100-736X2013000400014 DOI: https://doi.org/10.1590/S0100-736X2013000400014

Hayes Jr. H.M., Morin M.M. & Rubenstein D.A. 1983. Canine biliary carcinoma: epidemiological comparisons with man. Journal of Comparative Pathology. 93(1): 99-107. DOI: 10.1016/0021-9975(83)90047-6 DOI: https://doi.org/10.1016/0021-9975(83)90047-6

Jacobs M.T. & Snyder P.W. 2017. Mucinous Cholangiocarcinoma in a Cat. Journal of the American Animal Hospital Association. 43:168-172. DOI: 10.5326/0430168 DOI: https://doi.org/10.5326/0430168

Linden D.S., Liptak J.M., Vinayak A., Cappelle K., Hoffman C., Fan S., Smiley W. & Matz B.M. 2019. Outcomes and prognostic variables associated with central division hepatic lobectomies: 61 dogs. Veterinary Surgery. 48(3): 309-314. DOI: 10.1111/vsu.13164 DOI: https://doi.org/10.1111/vsu.13164

Martínez-Sogues L., Vila A., Roura X., Pastor J., Novellas R., Marco A., Maria Cuvertoret-Sanz M., Martínez J. & Solano-Gallego L. 2019. Hypercalcemia of malignancy in a dog diagnosed with cholangiocellular carcinoma. Topics in Companion Animal Medicine. 35:1-5. DOI: 10.1053/j.tcam.2019.02.001 DOI: https://doi.org/10.1053/j.tcam.2019.02.001

Patnaik A.K., Hurvitz A.I. & Lieberman PH. 1980. Canine hepatic neoplasms: a clinicopathologic study. Veterinary Pathology. 17(5): 533-564. DOI: 10.1177/030098588001700504 DOI: https://doi.org/10.1177/030098588001700504

Patnaik A.K., Hurvitz A.I., Lieberman P.H. & Johnson G.F. 1981. Canine Bile Duct Carcinoma. Veterinary Pathology. 18(4): 439-444. DOI: 10.1177/030098588101800403 DOI: https://doi.org/10.1177/030098588101800403

Ramos-Vara J.A., Miller M.A. & Johnson G.C. 2001. Immunohistochemical characterization of canine hyperplastic hepatic lesions and hepatocellular and biliary neoplasms with monoclonal antibody hepatocyte paraffin 1 and a monoclonal antibody to cytokeratin 7. Veterinary Pathology. 38(6): 636-643. DOI: 10.1354/vp.38-6-636 DOI: https://doi.org/10.1354/vp.38-6-636

Selmic L.E. 2017. Hepatobiliary Neoplasia. Veterinary Clinics of North America: Small Animal Practice. 47(3): 725-735. DOI: 10.1016/j.cvsm.2016.11.016 DOI: https://doi.org/10.1016/j.cvsm.2016.11.016

Setoyama T., Miyamoto S., Horimatsu T., Funakoshi T., Nikaido M., Kodama Y., Minamiguchi S., Yamabata T., Muto M. & Chiba T. 2014. Bioactive insulin-like growth factors as a possible molecular target for non-islet cell tumor hypoglycemia. Cancer Biology & Therapy. 5(12): 1588-1592. DOI: 10.4161/15384047.2014.961878 DOI: https://doi.org/10.4161/15384047.2014.961878

Trindade A.B. 2018. Clinical and Surgical Management of Dog with Diffuse Cholangiocarcinoma. Acta Scientiae Veterinariae. 46(1): 290. DOI: 10.22456/1679-9216.86822 DOI: https://doi.org/10.22456/1679-9216.86822

Tsuji Y., Kuramochi M., Izawa T., Akiyoshi H., Yamate J. & Kuwamura M. 2019. Hepatic myoepithelial carcinoma in a dog: immunohistochemical comparison with other canine hepatic carcinomas. Veterinary Pathology. 56(6): 889-894. DOI: 10.1177/0300985819854439 DOI: https://doi.org/10.1177/0300985819854439

Vail D.M., Thamm D.H. & Liptak J.M. 2020. Withrow & MacEwen’s Small Animal Clinical Oncology. 6th edn. St. Louis: Elsevier, pp.454-460.

van Sprundel R.G., van Den Ingh T.S., Guscetti F., Kershaw O., Kanemoto H., van Gils H.M., Rothuizen J., Roskams T. & Spee B. 2013. Classification of primary hepatic tumours in the dog. The Veterinary Journal. 197(3): 596-606. DOI: 10.1016/j.tvjl.2013.05.027 DOI: https://doi.org/10.1016/j.tvjl.2013.05.027

Vulpe V., Meomartino L., Vulpe C.A., Pașca S.A., Baisan R.A., Bondoc I.E. & Papuc I. 2019. The clinical, imaging and microscopic evaluation of hepatic tumoral processes in dogs. Romanian Biotechnological Letters. 24(4): 616-624. DOI: 10.25083/rbl/24.4/616.624 DOI: https://doi.org/10.25083/rbl/24.4/616.624

Additional Files

Published

2023-02-13

How to Cite

de Paiva, F. N., Santos Oliveira, G., Abranches de Souza, S., Cardim de Oliveira, P., Souza Costa, T., & Israel Fernandes, J. (2023). Cholangiocarcinoma in a Bitch - Multimodal Diagnosis. Acta Scientiae Veterinariae, 51. https://doi.org/10.22456/1679-9216.124365